London, UK – 4 October 2017 – Desktop Genetics Ltd (DTG), a software company revolutionising the way biologists use CRISPR genome editing technology, and online investment platform SyndicateRoom today announce the opening of a £1.5 million investment round. DTG plans to use the funds to commercialise products and support its expansion into the US.
DTG uses artificial intelligence (AI) to enable scientists and researchers to capitalise on genome engineering technology. Since its launch in 2012, the company has developed an industry-leading software platform to design and manufacture CRISPR1 genome editing reagents, and has developed and refined products which are now ready for launch.
The genome engineering market is estimated to be worth approximately $2.84 billion globally, and set to grow to more than $6 billion by 2021, by which time it is estimated that between 60,000 and 100,000 labs will be using CRISPR technology. Despite this, over half of all ...
